![ACE2 as a potential therapeutic target for pandemic COVID-19 - RSC Advances (RSC Publishing) DOI:10.1039/D0RA08228G ACE2 as a potential therapeutic target for pandemic COVID-19 - RSC Advances (RSC Publishing) DOI:10.1039/D0RA08228G](https://pubs.rsc.org/image/article/2020/RA/d0ra08228g/d0ra08228g-f1_hi-res.gif)
ACE2 as a potential therapeutic target for pandemic COVID-19 - RSC Advances (RSC Publishing) DOI:10.1039/D0RA08228G
![The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based cardiovascular therapies | Internal and Emergency Medicine The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based cardiovascular therapies | Internal and Emergency Medicine](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs11739-020-02364-6/MediaObjects/11739_2020_2364_Fig2_HTML.png)
The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based cardiovascular therapies | Internal and Emergency Medicine
![SARS-CoV-2 receptor ACE2-dependent implications on the cardiovascular system: From basic science to clinical implications - ScienceDirect SARS-CoV-2 receptor ACE2-dependent implications on the cardiovascular system: From basic science to clinical implications - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0022282820301218-ga1.jpg)
SARS-CoV-2 receptor ACE2-dependent implications on the cardiovascular system: From basic science to clinical implications - ScienceDirect
![Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target | Intensive Care Medicine Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target | Intensive Care Medicine](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs00134-020-05985-9/MediaObjects/134_2020_5985_Fig1_HTML.png)
Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target | Intensive Care Medicine
![SARS-CoV-2 and ACE2: The biology and clinical data settling the ARB and ACEI controversy - eBioMedicine SARS-CoV-2 and ACE2: The biology and clinical data settling the ARB and ACEI controversy - eBioMedicine](https://www.thelancet.com/cms/attachment/022235ff-1cc7-4a73-9112-39bf9c0edae6/gr2_lrg.jpg)
SARS-CoV-2 and ACE2: The biology and clinical data settling the ARB and ACEI controversy - eBioMedicine
![IJMS | Free Full-Text | Do Changes in ACE-2 Expression Affect SARS-CoV-2 Virulence and Related Complications: A Closer Look into Membrane-Bound and Soluble Forms IJMS | Free Full-Text | Do Changes in ACE-2 Expression Affect SARS-CoV-2 Virulence and Related Complications: A Closer Look into Membrane-Bound and Soluble Forms](https://pub.mdpi-res.com/ijms/ijms-22-06703/article_deploy/html/images/ijms-22-06703-g001.png?1624524857)
IJMS | Free Full-Text | Do Changes in ACE-2 Expression Affect SARS-CoV-2 Virulence and Related Complications: A Closer Look into Membrane-Bound and Soluble Forms
Role of angiotensin-converting enzyme 2 in neurodegenerative diseases during the COVID-19 pandemic | Aging
![ACE inhibitors, angiotensin receptor blockers and endothelial injury in COVID‐19 - Tetlow - 2021 - Journal of Internal Medicine - Wiley Online Library ACE inhibitors, angiotensin receptor blockers and endothelial injury in COVID‐19 - Tetlow - 2021 - Journal of Internal Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/beaf4217-1fdc-4755-a4c9-ee85e0e06c70/joim13202-toc-0001-m.jpg)
ACE inhibitors, angiotensin receptor blockers and endothelial injury in COVID‐19 - Tetlow - 2021 - Journal of Internal Medicine - Wiley Online Library
![COVID-19, ACE -inhibitors and angiotensin receptor blockers: The need to differentiate between early infection and acute lung injury COVID-19, ACE -inhibitors and angiotensin receptor blockers: The need to differentiate between early infection and acute lung injury](http://www.scielo.org.co/img/revistas/rcca/v27n3//0120-5633-rcca-27-03-129-gf1.jpg)
COVID-19, ACE -inhibitors and angiotensin receptor blockers: The need to differentiate between early infection and acute lung injury
![What is the ACE2 receptor, how is it connected to coronavirus and why might it be key to treating COVID-19? The experts explain What is the ACE2 receptor, how is it connected to coronavirus and why might it be key to treating COVID-19? The experts explain](https://images.theconversation.com/files/334882/original/file-20200514-167762-9vl8um.jpg?ixlib=rb-1.1.0&q=45&auto=format&w=1000&fit=clip)
What is the ACE2 receptor, how is it connected to coronavirus and why might it be key to treating COVID-19? The experts explain
![SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy](https://www.thno.org/v10/p7448/toc.jpg)
SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy
![ACE inhibition, ACE2 and angiotensin-(17) axis in kidney and cardiac inflammation and fibrosis - ScienceDirect ACE inhibition, ACE2 and angiotensin-(17) axis in kidney and cardiac inflammation and fibrosis - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1043661816301955-fx1.jpg)
ACE inhibition, ACE2 and angiotensin-(17) axis in kidney and cardiac inflammation and fibrosis - ScienceDirect
![IJMS | Free Full-Text | ACE2 and Innate Immunity in the Regulation of SARS-CoV-2-Induced Acute Lung Injury: A Review IJMS | Free Full-Text | ACE2 and Innate Immunity in the Regulation of SARS-CoV-2-Induced Acute Lung Injury: A Review](https://pub.mdpi-res.com/ijms/ijms-22-11483/article_deploy/html/images/ijms-22-11483-g001.png?1635159233)
IJMS | Free Full-Text | ACE2 and Innate Immunity in the Regulation of SARS-CoV-2-Induced Acute Lung Injury: A Review
![Angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers in COVID-19 - The Centre for Evidence-Based Medicine Angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers in COVID-19 - The Centre for Evidence-Based Medicine](https://www.cebm.net/wp-content/uploads/2020/03/RAS2.jpg)
Angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers in COVID-19 - The Centre for Evidence-Based Medicine
![Molecules | Free Full-Text | Is It Still Relevant to Discover New ACE Inhibitors from Natural Products? YES, but Only with Comprehensive Approaches to Address the Patients’ Real Problems: Chronic Dry Cough Molecules | Free Full-Text | Is It Still Relevant to Discover New ACE Inhibitors from Natural Products? YES, but Only with Comprehensive Approaches to Address the Patients’ Real Problems: Chronic Dry Cough](https://pub.mdpi-res.com/molecules/molecules-28-04532/article_deploy/html/images/molecules-28-04532-g001-550.jpg?1685719723)
Molecules | Free Full-Text | Is It Still Relevant to Discover New ACE Inhibitors from Natural Products? YES, but Only with Comprehensive Approaches to Address the Patients’ Real Problems: Chronic Dry Cough
![Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID19 | Signal Transduction and Targeted Therapy Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID19 | Signal Transduction and Targeted Therapy](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41392-020-00374-6/MediaObjects/41392_2020_374_Fig1_HTML.png)